People should always confirm which drugs have FDA approval for weight loss before starting them
reports research support grants from Akero, AstraZeneca, Boehringer Ingelheim, BMS, 89bio, Eli Lilly & Company, Intercept, IONIS, Janssen, Madrigal, Metacrine, Merck, NorthSea Therapeutics, Novartis, Novo Nordisk, Oramed, Pfizer, Poxel and Sanofi
Plausible Contributors Beyond the Drug Itself The labeled indications specify use in combination with a reduced-calorie diet and increased physical activity, and in the trials participants received instruction for an approximately 500 kcal/day deficit
long-term use Although short-term use appears relatively safe, the long-term effects remain less certain
Understanding what happens during the injection and applying simple preparation strategies can reduce anxiety and virtually eliminate discomfort
On average, patients may lose 5-10% of their body weight within this timeframe